Literature DB >> 11415958

Commentary: practical advantages of Bayesian analysis of epidemiologic data.

D B Dunson1.   

Abstract

In the past decade, there have been enormous advances in the use of Bayesian methodology for analysis of epidemiologic data, and there are now many practical advantages to the Bayesian approach. Bayesian models can easily accommodate unobserved variables such as an individual's true disease status in the presence of diagnostic error. The use of prior probability distributions represents a powerful mechanism for incorporating information from previous studies and for controlling confounding. Posterior probabilities can be used as easily interpretable alternatives to p values. Recent developments in Markov chain Monte Carlo methodology facilitate the implementation of Bayesian analyses of complex data sets containing missing observations and multidimensional outcomes. Tools are now available that allow epidemiologists to take advantage of this powerful approach to assessment of exposure-disease relations.

Mesh:

Year:  2001        PMID: 11415958     DOI: 10.1093/aje/153.12.1222

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  64 in total

1.  A Bayesian approach to dose-response assessment and synergy and its application to in vitro dose-response studies.

Authors:  Violeta G Hennessey; Gary L Rosner; Robert C Bast; Min-Yu Chen
Journal:  Biometrics       Date:  2010-12       Impact factor: 2.571

2.  Bayesian mapping of quantitative trait loci for multiple complex traits with the use of variance components.

Authors:  Jianfeng Liu; Yongjun Liu; Xiaogang Liu; Hong-Wen Deng
Journal:  Am J Hum Genet       Date:  2007-07-03       Impact factor: 11.025

Review 3.  The contrast and convergence of Bayesian and frequentist statistical approaches in pharmacoeconomic analysis.

Authors:  Grant H Skrepnek
Journal:  Pharmacoeconomics       Date:  2007       Impact factor: 4.981

4.  Augmented mixed beta regression models for periodontal proportion data.

Authors:  Diana M Galvis; Dipankar Bandyopadhyay; Victor H Lachos
Journal:  Stat Med       Date:  2014-04-24       Impact factor: 2.373

5.  Turning the Bayesian crank.

Authors:  Richard F MacLehose; J Michael Oakes; Bradley P Carlin
Journal:  Epidemiology       Date:  2011-05       Impact factor: 4.822

6.  Predicting abdominal aortic aneurysm growth using patient-oriented growth models with two-step Bayesian inference.

Authors:  Emrah Akkoyun; Sebastian T Kwon; Aybar C Acar; Whal Lee; Seungik Baek
Journal:  Comput Biol Med       Date:  2020-01-13       Impact factor: 4.589

7.  Does the 5-HT1A rs6295 polymorphism influence the safety and efficacy of citalopram therapy in the oldest old?

Authors:  Greg Scutt; Andrew Overall; Railton Scott; Bhavik Patel; Lamia Hachoumi; Mark Yeoman; Juliet Wright
Journal:  Ther Adv Drug Saf       Date:  2018-04-23

8.  Bayesian methods for correcting misclassification: an example from birth defects epidemiology.

Authors:  Richard F MacLehose; Andrew F Olshan; Amy H Herring; Margaret A Honein; Gary M Shaw; Paul A Romitti
Journal:  Epidemiology       Date:  2009-01       Impact factor: 4.822

9.  Augmented mixed models for clustered proportion data.

Authors:  Dipankar Bandyopadhyay; Diana M Galvis; Victor H Lachos
Journal:  Stat Methods Med Res       Date:  2014-12-08       Impact factor: 3.021

10.  Methodological issues in studies of air pollution and reproductive health.

Authors:  Tracey J Woodruff; Jennifer D Parker; Lyndsey A Darrow; Rémy Slama; Michelle L Bell; Hyunok Choi; Svetlana Glinianaia; Katherine J Hoggatt; Catherine J Karr; Danelle T Lobdell; Michelle Wilhelm
Journal:  Environ Res       Date:  2009-02-11       Impact factor: 6.498

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.